Stuart Preston, business development manager, Mettler Toledo discusses how in pharmaceutical manufacturing, contamination control begins long before products reach final packaging.
In pharmaceutical manufacturing, inspection plays a critical role in process control to examine individual products, primary packs, or finished cartons, depending on the application. Adam Green, market manager, Mettler Toledo discusses.
Brandon Hoser, business development & marketing at PackworldUSA discusses turning lab seal data into production-ready parameters for modern flexible packaging.
For operators of straddle carriers at a busy container port, the ability to identify container configurations accurately and automatically has become a critical factor in improving efficiency, reducing operator workload, and maximising yard capacity.
Antibody-drug conjugates (ADCs) are advancing cancer treatment, but their success depends on early safety insights and informed toxicology strategies. Xiaoxiao Wang, Yan Zhang, Junli Zhao, WuXi AppTec explains.
Bürkert’s segment manager for Hygienic-Pharmaceutical, Damien Moran, explains how intelligent, automated PW and WFI sub-loops with hygienic flow measurement and valve technology help minimise biofilm risk while ensuring controlled circulation.
Automated quality inspection has a reputation problem. If you ask production managers why they haven't implemented it yet, the might include: too complex, too expensive, requires expertise we don't have.
When it comes to pharmaceutical manufacturing, precision is more than a performance goal, it is a regulatory necessity. Miriam Krechlok, segment marketing manager, Mettler-Toledo Product Inspection discusses.
When pharmaceutical facilities can cost hundreds of millions of euros, getting the numbers right from the outset is critical. Boehringer Ingelheim explains how it is combining AI, historical project data and robust governance.
Imperial Brands Science examines how Toxicity Testing is helping to reshape biological testing by focusing on the mechanisms that drive toxicity and disease, and what this could mean for future product development and consumer safeguarding.
